National Institutes of Health funds the Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults

by: Iola Bonggay

The National Institutes of Health, otherwise known as NIH, is an agency that is operating under the United States Department of Human Health and Services.

The NIH is largely responsible for conducting the country's most innovative bio-medical and health-related research studies.

The efforts of the NIH have been constantly geared towards making important and innovative medical decisions that would benefit the health of everyone.

The National Institutes of Health has recently established a program entitled Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults wherein they intend to kick-off research studies that will create, implement, and evaluate both old and new interventions that are geared towards improving adherence to medical and behavioral regimens for HIV-positive adolescents which are 11 to 21 years old and adults who are 21 to 24 years old.

In order to achieve the objectives of the program, the NIH has outlined that the recipients of the grant should conduct studies that will look into individual, family, social, political, and contextual factors that could potentially influence adherence.

Furthermore, the NIH also requires that as a response to the data gathered from the studies, the recipients of the grant must also develop innovative measures of adherence or refine existing measures in order to make them better and more efficient.

The end goal of the Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults is to alleviate or totally lessen the possibility of HIV transmission and to improve the outcomes in HIV-positive adolescents and adults.

  (continued...)

National Institutes of Health funds the Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Human Health and Heredity in Africa: Research Grants Program
The Human Health and Heredity in Africa: Research Grants Program wherein they intend to invite applications from foreign institutions that are based in African countries who have the desire to conduct scientific studies regarding the genomic/genetic/environmental contributors of human health and diseases which are common in Africa.

---

Health Care Innovation Challenge
The Centers for Medicare and & Medicaid Services has recently established the Health Care Innovation Challenge in an attempt to solicit proposals to establish interesting new models of service delivery that can potentially deliver the three-part aim of better health, better health care, and finally, lower costs through the improved quality of Medicare, Medicaid, and Children's Health Insurance Program.

---

Genomic Advances to Wound Repair
The National Institutes of Health has coordinated with the National Institute of Nursing Research (NINR) to establish a program called Genomic Advances to Wound Repair in an effort to jump-start research studies that have the potential to deepen the understanding of genomic mechanism associated with the repair and development of wounds that are chronic in nature, which implies that these wounds have failed to enter into a reparative process after three months.

---

Exploratory Clinical Trials for Small Business Grant Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) in order to establish the Exploratory Clinical Trials for Small Business Grant Program wherein they aim to establish a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NIND

---